Last time I’ve introduced the principle of life’s default positivity, and the first formula provided was the one used by Thomas Nagel in his Death essay:
It is good simply to be alive.
Another way to phrase this is comparatively
It’s better to be alive than dead.
Let me introduce now a potential counterargument, extracted from the words of one of my favourite fictional characters, Rosencrantz, played by Garry Oldman in Stoppard’s Rosencrantz and Guildenstern are dead. Mind you, this is Stoppard’s but not Shakespeare’s Rosencrantz, speaking. How about watching it first:
Here’s the corresponding section from the script: Continue reading “Is life in a box is better than no life at all? Help and hope, so.”
It is good simply to be alive, even if one is undergoing terrible experiences.
So first formula
1. It is good simply to be alive.
Our daily today is posing a heavy philosophical question: can we build a better self without building a better world? For understanding the level of this question one needs to take a moral/ethical concept of the self granted. But we don’t need to dig into the depth of the malleability of personal identity, but mostly focus on our narrative, social construct of our selves that is a prime bearer of moral values and changes and agent of moral decisions. Continue reading “Daily Effort: Can we build a better self without building a better world?”
In the opening post of this blog I started by saying ‘Life extension’ as a term referring to healthy longevity technologies and attempts just does not cut it anymore and I cited luxury as one reason. There’s another important reason, coming from the already existing medical use of this term to ditch this concept to be used for our Open Lifespan purposes. The terms ‘life extension’, ‘extending life’ are used in the medical context to provide extra days, weeks, months to late stage, terminally diseased people, think of a final stage lung cancer patient. Continue reading “Daily Effort: Life extension belongs to the ICU, Open Lifespan belongs to everybody”
Attempting a new post series called Daily Effort: a dense expression of an Open Lifespan/Open Healthspan related idea (question, argument, proposal …) in a couple of sentences. Without context or tight, detailed argumentation. Consider these as drafts, some of them will be elaborated upon, some of them will be revoked if don’t stand up to scrutiny. In any case, these are my drafts here am working on, reaching a stage where it might be interesting for others too. Let’s go.
Today’s idea is simple and I phrase it as a question (and a bundle of follow-up questions), rather than a proposal as originally intended: if a drug has reported and potential lifespan and/or healthspan lengthening benefits, should this information be printed on the label too amongst potential side effects? Think of metformin here as a prime example where observational evidence suggests longer survival time for metformin user diabetics compared to non-diabetic, non-users. Continue reading “Daily Effort: Pharmacodiligence plus, potential, positive lifespan side effects on drug labels?”